The University of Chicago Header Logo

Connection

Marsha Rosner to Humans

This is a "connection" page, showing publications Marsha Rosner has written about Humans.
Connection Strength

0.778
  1. Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism. Nature. 2019 04; 568(7751):254-258.
    View in: PubMed
    Score: 0.023
  2. Raf kinase inhibitor protein: lessons of a better way for ß-adrenergic receptor activation in the heart. J Physiol. 2017 06 15; 595(12):4073-4087.
    View in: PubMed
    Score: 0.020
  3. Gene expression in local stroma reflects breast tumor states and predicts patient outcome. Sci Rep. 2016 12 16; 6:39240.
    View in: PubMed
    Score: 0.020
  4. Metastasis Suppressors Regulate the Tumor Microenvironment by Blocking Recruitment of Prometastatic Tumor-Associated Macrophages. Cancer Res. 2015 Oct 01; 75(19):4063-73.
    View in: PubMed
    Score: 0.018
  5. Raf kinase inhibitory protein (RKIP) as a metastasis suppressor: regulation of signaling networks in cancer. Crit Rev Oncog. 2014; 19(6):447-54.
    View in: PubMed
    Score: 0.016
  6. RKIP structure drives its function: a three-state model for regulation of RKIP. Crit Rev Oncog. 2014; 19(6):483-8.
    View in: PubMed
    Score: 0.016
  7. A prognostic gene signature for metastasis-free survival of triple negative breast cancer patients. PLoS One. 2013; 8(12):e82125.
    View in: PubMed
    Score: 0.016
  8. RKIP and HMGA2 regulate breast tumor survival and metastasis through lysyl oxidase and syndecan-2. Oncogene. 2014 Jul 03; 33(27):3528-37.
    View in: PubMed
    Score: 0.016
  9. HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis. Proc Natl Acad Sci U S A. 2013 Jun 11; 110(24):9920-5.
    View in: PubMed
    Score: 0.015
  10. A novel interplay between Rap1 and PKA regulates induction of angiogenesis in prostate cancer. PLoS One. 2012; 7(11):e49893.
    View in: PubMed
    Score: 0.015
  11. Identification of novel metastasis suppressor signaling pathways for breast cancer. Cell Cycle. 2012 Jul 01; 11(13):2452-7.
    View in: PubMed
    Score: 0.014
  12. Nonheritable cellular variability accelerates the evolutionary processes of cancer. PLoS Biol. 2012; 10(4):e1001296.
    View in: PubMed
    Score: 0.014
  13. Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer. EMBO J. 2011 Aug 26; 30(21):4500-14.
    View in: PubMed
    Score: 0.014
  14. Nucleocytoplasmic localization of p70 S6K1, but not of its isoforms p85 and p31, is regulated by TSC2/mTOR. Oncogene. 2011 Nov 03; 30(44):4509-22.
    View in: PubMed
    Score: 0.013
  15. Evidence for cell cycle-dependent, rapamycin-resistant phosphorylation of ribosomal protein S6 at S240/244. Amino Acids. 2010 Nov; 39(5):1487-92.
    View in: PubMed
    Score: 0.012
  16. MAP kinase regulation of the mitotic spindle checkpoint. Methods Mol Biol. 2010; 661:497-505.
    View in: PubMed
    Score: 0.012
  17. CDKs as therapeutic targets for the human genetic disease tuberous sclerosis? Eur J Clin Invest. 2009 Dec; 39(12):1033-5.
    View in: PubMed
    Score: 0.012
  18. A novel interplay between Epac/Rap1 and mitogen-activated protein kinase kinase 5/extracellular signal-regulated kinase 5 (MEK5/ERK5) regulates thrombospondin to control angiogenesis. Blood. 2009 Nov 12; 114(20):4592-600.
    View in: PubMed
    Score: 0.012
  19. MicroRNA-regulated feed forward loop network. Cell Cycle. 2009 Aug 15; 8(16):2477-8.
    View in: PubMed
    Score: 0.012
  20. Raf Kinase Inhibitory Protein protects cells against locostatin-mediated inhibition of migration. PLoS One. 2009 Jun 24; 4(6):e6028.
    View in: PubMed
    Score: 0.012
  21. Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7. EMBO J. 2009 Feb 18; 28(4):347-58.
    View in: PubMed
    Score: 0.011
  22. A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle. Cancer Res. 2009 Jan 01; 69(1):65-74.
    View in: PubMed
    Score: 0.011
  23. Raf kinase inhibitory protein function is regulated via a flexible pocket and novel phosphorylation-dependent mechanism. Mol Cell Biol. 2009 Mar; 29(5):1306-20.
    View in: PubMed
    Score: 0.011
  24. Raf kinase inhibitory protein (RKIP): a physiological regulator and future therapeutic target. Expert Opin Ther Targets. 2008 Oct; 12(10):1275-87.
    View in: PubMed
    Score: 0.011
  25. Tuberin, p27 and mTOR in different cells. Amino Acids. 2009 Feb; 36(2):297-302.
    View in: PubMed
    Score: 0.011
  26. Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor. Cell Res. 2008 Apr; 18(4):452-7.
    View in: PubMed
    Score: 0.011
  27. Anthrax edema toxin inhibits endothelial cell chemotaxis via Epac and Rap1. J Biol Chem. 2007 Jul 06; 282(27):19781-7.
    View in: PubMed
    Score: 0.010
  28. Cytoplasmic/nuclear localization of tuberin in different cell lines. Amino Acids. 2007 Nov; 33(4):575-9.
    View in: PubMed
    Score: 0.010
  29. Raf kinase inhibitory protein regulates aurora B kinase and the spindle checkpoint. Mol Cell. 2006 Aug; 23(4):561-74.
    View in: PubMed
    Score: 0.010
  30. Akt regulates nuclear/cytoplasmic localization of tuberin. Oncogene. 2007 Jan 25; 26(4):521-31.
    View in: PubMed
    Score: 0.009
  31. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase. Cancer Res. 2006 Jun 15; 66(12):6296-303.
    View in: PubMed
    Score: 0.009
  32. Tuberin activates the proapoptotic molecule BAD. Oncogene. 2006 Oct 19; 25(49):6467-79.
    View in: PubMed
    Score: 0.009
  33. CDKL5/Stk9 kinase inactivation is associated with neuronal developmental disorders. Hum Mol Genet. 2005 Dec 15; 14(24):3775-86.
    View in: PubMed
    Score: 0.009
  34. Anthrax edema factor potency depends on mode of cell entry. Biochem Biophys Res Commun. 2005 Sep 30; 335(3):850-7.
    View in: PubMed
    Score: 0.009
  35. 14-3-3 proteins are involved in the regulation of mammalian cell proliferation. Amino Acids. 2006 Feb; 30(1):105-9.
    View in: PubMed
    Score: 0.009
  36. Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation. J Biol Chem. 2005 Jul 01; 280(26):24931-40.
    View in: PubMed
    Score: 0.009
  37. Modulation of the MAP kinase signaling cascade by Raf kinase inhibitory protein. Cell Res. 2005 Jan; 15(1):19-23.
    View in: PubMed
    Score: 0.009
  38. Proteins interacting with the tuberous sclerosis gene products. Amino Acids. 2004 Oct; 27(2):119-28.
    View in: PubMed
    Score: 0.008
  39. ERK7 expression and kinase activity is regulated by the ubiquitin-proteosome pathway. J Biol Chem. 2004 May 28; 279(22):23073-81.
    View in: PubMed
    Score: 0.008
  40. Nonmonotone invasion landscape by noise-aware control of metastasis activator levels. Nat Chem Biol. 2023 07; 19(7):887-899.
    View in: PubMed
    Score: 0.008
  41. Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. J Biol Chem. 2003 Apr 11; 278(15):13061-8.
    View in: PubMed
    Score: 0.007
  42. SARS-CoV-2 Diverges from Other Betacoronaviruses in Only Partially Activating the IRE1a/XBP1 Endoplasmic Reticulum Stress Pathway in Human Lung-Derived Cells. mBio. 2022 10 26; 13(5):e0241522.
    View in: PubMed
    Score: 0.007
  43. Raf Kinase Inhibitory Protein regulates the cAMP-dependent protein kinase signaling pathway through a positive feedback loop. Proc Natl Acad Sci U S A. 2022 06 21; 119(25):e2121867119.
    View in: PubMed
    Score: 0.007
  44. Characterization of a cysteine proteinase inhibitor induced during neuronal cell differentiation. J Neurochem. 2002 Jun; 81(5):922-34.
    View in: PubMed
    Score: 0.007
  45. ERK8, a new member of the mitogen-activated protein kinase family. J Biol Chem. 2002 May 10; 277(19):16733-43.
    View in: PubMed
    Score: 0.007
  46. Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses. Sci Adv. 2022 Feb 25; 8(8):eabi6110.
    View in: PubMed
    Score: 0.007
  47. New strategies for targeting kinase networks in cancer. J Biol Chem. 2021 10; 297(4):101128.
    View in: PubMed
    Score: 0.007
  48. Limited inhibition of multiple nodes in a driver network blocks metastasis. Elife. 2021 05 11; 10.
    View in: PubMed
    Score: 0.007
  49. Cloning and characterization of MST4, a novel Ste20-like kinase. J Biol Chem. 2001 Jun 22; 276(25):22439-45.
    View in: PubMed
    Score: 0.007
  50. A novel mitogen-activated protein kinase is responsive to Raf and mediates growth factor specificity. Mol Cell Biol. 2001 Mar; 21(6):2235-47.
    View in: PubMed
    Score: 0.007
  51. The TSC1 gene product, hamartin, negatively regulates cell proliferation. Hum Mol Genet. 2000 Jul 22; 9(12):1721-7.
    View in: PubMed
    Score: 0.006
  52. Functional human insulin-degrading enzyme can be expressed in bacteria. Protein Expr Purif. 2000 Jun; 19(1):91-8.
    View in: PubMed
    Score: 0.006
  53. Metabolically activated adipose tissue macrophages link obesity to triple-negative breast cancer. J Exp Med. 2019 06 03; 216(6):1345-1358.
    View in: PubMed
    Score: 0.006
  54. Molecular cloning and characterization of a mitogen-activated protein kinase-associated intracellular chloride channel. J Biol Chem. 1999 Jan 15; 274(3):1621-7.
    View in: PubMed
    Score: 0.006
  55. Raf and fibroblast growth factor phosphorylate Elk1 and activate the serum response element of the immediate early gene pip92 by mitogen-activated protein kinase-independent as well as -dependent signaling pathways. Mol Cell Biol. 1998 Apr; 18(4):2272-81.
    View in: PubMed
    Score: 0.005
  56. Conserved salt-bridge competition triggered by phosphorylation regulates the protein interactome. Proc Natl Acad Sci U S A. 2017 12 19; 114(51):13453-13458.
    View in: PubMed
    Score: 0.005
  57. Insulin-degrading enzyme does not require peroxisomal localization for insulin degradation. Endocrinology. 1997 Aug; 138(8):3444-51.
    View in: PubMed
    Score: 0.005
  58. Apoptosis induced by differentiation or serum deprivation in an immortalized central nervous system neuronal cell line. J Neurochem. 1996 Nov; 67(5):1908-20.
    View in: PubMed
    Score: 0.005
  59. Interaction of tRNA with MEK2 in pancreatic cancer cells. Sci Rep. 2016 06 15; 6:28260.
    View in: PubMed
    Score: 0.005
  60. Raf, but not MEK or ERK, is sufficient for differentiation of hippocampal neuronal cells. Mol Cell Biol. 1996 Apr; 16(4):1458-70.
    View in: PubMed
    Score: 0.005
  61. Noise-Driven Phenotypic Heterogeneity with Finite Correlation Time in Clonal Populations. PLoS One. 2015; 10(7):e0132397.
    View in: PubMed
    Score: 0.004
  62. Identification of zinc ligands of the insulin-degrading enzyme. J Biol Chem. 1994 Dec 30; 269(52):33140-5.
    View in: PubMed
    Score: 0.004
  63. Conceptualizing cancer drugs as classifiers. PLoS One. 2014; 9(9):e106444.
    View in: PubMed
    Score: 0.004
  64. Induction of epidermal growth factor receptor gene transcription by transforming growth factor beta 1: association with loss of protein binding to a negative regulatory element. Cell Growth Differ. 1994 Aug; 5(8):801-9.
    View in: PubMed
    Score: 0.004
  65. Patient dissatisfaction after functionally successful conjunctivodacryocystorhinostomy with Jones tube. Am J Ophthalmol. 1994 May 15; 117(5):636-42.
    View in: PubMed
    Score: 0.004
  66. Identification of an epidermal growth factor receptor transcriptional repressor. J Biol Chem. 1994 Feb 11; 269(6):4307-12.
    View in: PubMed
    Score: 0.004
  67. Network of mutually repressive metastasis regulators can promote cell heterogeneity and metastatic transitions. Proc Natl Acad Sci U S A. 2014 Jan 21; 111(3):E364-73.
    View in: PubMed
    Score: 0.004
  68. Functional analysis of conserved residues in the active site of insulin-degrading enzyme. J Biol Chem. 1993 Oct 15; 268(29):21538-44.
    View in: PubMed
    Score: 0.004
  69. Mutations in a zinc-binding domain of human insulin-degrading enzyme eliminate catalytic activity but not insulin binding. J Biol Chem. 1993 Apr 15; 268(11):7943-8.
    View in: PubMed
    Score: 0.004
  70. RKIP inhibition in cervical cancer is associated with higher tumor aggressive behavior and resistance to cisplatin therapy. PLoS One. 2013; 8(3):e59104.
    View in: PubMed
    Score: 0.004
  71. Overexpression of initiator methionine tRNA leads to global reprogramming of tRNA expression and increased proliferation in human epithelial cells. RNA. 2013 Apr; 19(4):461-6.
    View in: PubMed
    Score: 0.004
  72. Insulin-degrading enzyme is differentially expressed and developmentally regulated in various rat tissues. Endocrinology. 1993 Feb; 132(2):604-11.
    View in: PubMed
    Score: 0.004
  73. Activation of MAP kinases by calcium-dependent and calcium-independent pathways. Stimulation by thapsigargin and epidermal growth factor. J Biol Chem. 1992 Oct 05; 267(28):19876-83.
    View in: PubMed
    Score: 0.004
  74. Anti-tumor effects of an engineered "killer" transfer RNA. Biochem Biophys Res Commun. 2012 Oct 12; 427(1):148-53.
    View in: PubMed
    Score: 0.004
  75. Structurally different members of the okadaic acid class selectively inhibit protein serine/threonine but not tyrosine phosphatase activity. Toxicon. 1992 Aug; 30(8):873-8.
    View in: PubMed
    Score: 0.004
  76. Downregulation of RKIP is associated with poor outcome and malignant progression in gliomas. PLoS One. 2012; 7(1):e30769.
    View in: PubMed
    Score: 0.003
  77. An integrated view of cyclin E function and regulation. Cell Cycle. 2012 Jan 01; 11(1):57-64.
    View in: PubMed
    Score: 0.003
  78. Proliferation potential of human amniotic fluid stem cells differently responds to mercury and lead exposure. Amino Acids. 2012 Aug; 43(2):937-49.
    View in: PubMed
    Score: 0.003
  79. Regulation of insulin degradation: expression of an evolutionarily conserved insulin-degrading enzyme increases degradation via an intracellular pathway. Mol Endocrinol. 1991 Oct; 5(10):1467-76.
    View in: PubMed
    Score: 0.003
  80. p70 S6K1 nuclear localization depends on its mTOR-mediated phosphorylation at T389, but not on its kinase activity towards S6. Amino Acids. 2012 Jun; 42(6):2251-6.
    View in: PubMed
    Score: 0.003
  81. Regulation of insulin, epidermal growth factor, and transforming growth factor-alpha levels by growth factor-degrading enzymes. Endocrinology. 1991 Mar; 128(3):1603-10.
    View in: PubMed
    Score: 0.003
  82. Cloning and expression of the cDNA for a Drosophila insulin-degrading enzyme. Mol Endocrinol. 1990 Oct; 4(10):1580-91.
    View in: PubMed
    Score: 0.003
  83. Efficacy of the multi-kinase inhibitor enzastaurin is dependent on cellular signaling context. Mol Cancer Ther. 2010 Oct; 9(10):2814-24.
    View in: PubMed
    Score: 0.003
  84. An evolutionarily conserved TGF-alpha/insulin-degrading enzyme. Mol Reprod Dev. 1990 Sep; 27(1):54-9.
    View in: PubMed
    Score: 0.003
  85. Different cytoplasmic/nuclear distribution of S6 protein phosphorylated at S240/244 and S235/236. Amino Acids. 2011 Feb; 40(2):595-600.
    View in: PubMed
    Score: 0.003
  86. Characterization of the Raf kinase inhibitory protein (RKIP) binding pocket: NMR-based screening identifies small-molecule ligands. PLoS One. 2010 May 05; 5(5):e10479.
    View in: PubMed
    Score: 0.003
  87. Regulation of the epidermal growth factor receptor by growth-modulating agents: effects of staurosporine, a protein kinase inhibitor. Cancer Res. 1990 Feb 01; 50(3):533-8.
    View in: PubMed
    Score: 0.003
  88. Innate immune and chemically triggered oxidative stress modifies translational fidelity. Nature. 2009 Nov 26; 462(7272):522-6.
    View in: PubMed
    Score: 0.003
  89. Embryoid body formation of human amniotic fluid stem cells depends on mTOR. Oncogene. 2010 Feb 18; 29(7):966-77.
    View in: PubMed
    Score: 0.003
  90. tRNA over-expression in breast cancer and functional consequences. Nucleic Acids Res. 2009 Nov; 37(21):7268-80.
    View in: PubMed
    Score: 0.003
  91. Basic and acidic fibroblast growth factors modulate the epidermal growth factor receptor by a protein kinase C-independent pathway. Biochem Biophys Res Commun. 1989 Oct 31; 164(2):796-803.
    View in: PubMed
    Score: 0.003
  92. Phosphorylation at threonine-654 is not required for negative regulation of the epidermal growth factor receptor by non-phorbol tumor promoters. Proc Natl Acad Sci U S A. 1989 Feb; 86(3):812-6.
    View in: PubMed
    Score: 0.003
  93. mTOR phosphorylated at S2448 binds to raptor and rictor. Amino Acids. 2010 Jan; 38(1):223-8.
    View in: PubMed
    Score: 0.003
  94. Thapsigargin, a novel promoter, phosphorylates the epidermal growth factor receptor at threonine 669. Biochem Biophys Res Commun. 1988 Dec 15; 157(2):740-6.
    View in: PubMed
    Score: 0.003
  95. Immunohistochemical evidence of ubiquitous distribution of the metalloendoprotease insulin-degrading enzyme (IDE; insulysin) in human non-malignant tissues and tumor cell lines. Biol Chem. 2008 Nov; 389(11):1441-5.
    View in: PubMed
    Score: 0.003
  96. Expression of metalloprotease insulin-degrading enzyme insulysin in normal and malignant human tissues. Int J Mol Med. 2008 Oct; 22(4):421-31.
    View in: PubMed
    Score: 0.003
  97. Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations. Endocr Relat Cancer. 2007 Dec; 14(4):1053-62.
    View in: PubMed
    Score: 0.003
  98. Ras mediates cell survival by regulating tuberin. Oncogene. 2008 Mar 27; 27(14):2072-83.
    View in: PubMed
    Score: 0.003
  99. Immunohistochemical demonstration of the zinc metalloprotease insulin-degrading enzyme in normal and malignant human breast: correlation with tissue insulin levels. Int J Oncol. 2007 Jan; 30(1):73-80.
    View in: PubMed
    Score: 0.002
  100. Characterization of rodent epidermal growth factor receptor transcripts using a mouse genomic probe. Biochem Biophys Res Commun. 1986 Dec 30; 141(3):1109-15.
    View in: PubMed
    Score: 0.002
  101. Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism. Nature. 2006 Oct 19; 443(7113):870-4.
    View in: PubMed
    Score: 0.002
  102. The C-terminal domain of human insulin degrading enzyme is required for dimerization and substrate recognition. Biochem Biophys Res Commun. 2006 May 19; 343(4):1032-7.
    View in: PubMed
    Score: 0.002
  103. Diacylglycerol modulates binding and phosphorylation of the epidermal growth factor receptor. J Biol Chem. 1984 Oct 25; 259(20):12502-7.
    View in: PubMed
    Score: 0.002
  104. Tumor promoters block tyrosine-specific phosphorylation of the epidermal growth factor receptor. Proc Natl Acad Sci U S A. 1984 May; 81(10):3034-8.
    View in: PubMed
    Score: 0.002
  105. Human bronchial smooth muscle cell lines show a hypertrophic phenotype typical of severe asthma. Am J Respir Crit Care Med. 2004 Mar 15; 169(6):703-11.
    View in: PubMed
    Score: 0.002
  106. The absence of NF-kappaB-mediated inhibition of c-Jun N-terminal kinase activation contributes to tumor necrosis factor alpha-induced apoptosis. Mol Cell Biol. 2002 Dec; 22(24):8571-9.
    View in: PubMed
    Score: 0.002
  107. Regulation of airway smooth muscle cyclin D1 transcription by protein kinase C-delta. Am J Respir Cell Mol Biol. 2002 Aug; 27(2):204-13.
    View in: PubMed
    Score: 0.002
  108. Tuberous sclerosis causing mutants of the TSC2 gene product affect proliferation and p27 expression. Oncogene. 2001 Aug 09; 20(35):4904-9.
    View in: PubMed
    Score: 0.002
  109. Tuberous sclerosis gene products in proliferation control. Mutat Res. 2001 Jul; 488(3):233-9.
    View in: PubMed
    Score: 0.002
  110. Purified recombinant insulin-degrading enzyme degrades amyloid beta-protein but does not promote its oligomerization. Biochem J. 2000 Oct 15; 351 Pt 2:509-16.
    View in: PubMed
    Score: 0.002
  111. Insulin-like growth factor I receptor signaling in differentiation of neuronal H19-7 cells. Cancer Res. 2000 Apr 15; 60(8):2263-72.
    View in: PubMed
    Score: 0.002
  112. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem. 1998 Dec 04; 273(49):32730-8.
    View in: PubMed
    Score: 0.001
  113. WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J. 1995 Oct 02; 14(19):4662-75.
    View in: PubMed
    Score: 0.001
  114. Hydrogen peroxide stimulates mitogen-activated protein kinase in bovine tracheal myocytes: implications for human airway disease. Am J Respir Cell Mol Biol. 1994 Nov; 11(5):577-85.
    View in: PubMed
    Score: 0.001
  115. Inducible expression and cellular localization of insulin-degrading enzyme in a stably transfected cell line. J Biol Chem. 1994 Sep 09; 269(36):22599-606.
    View in: PubMed
    Score: 0.001
  116. Adenovirus and protein kinase C have distinct molecular requirements for regulating epidermal growth factor receptor trafficking. J Cell Physiol. 1993 Dec; 157(3):535-43.
    View in: PubMed
    Score: 0.001
  117. Interactions between retroviruses and environmental carcinogens and their role in animal and human leukemogenesis. Leuk Res. 1992 Nov; 16(11):1061-9.
    View in: PubMed
    Score: 0.001
  118. Localization of the gene encoding insulin-degrading enzyme to human chromosome 10, bands q23----q25. Cytogenet Cell Genet. 1991; 57(4):184-6.
    View in: PubMed
    Score: 0.001
  119. Substance abuse in pregnant women: recent experience at the Perinatal Center for Chemical Dependence of Northwestern Memorial Hospital. Obstet Gynecol. 1989 May; 73(5 Pt 1):715-20.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.